doi: 10.3389/fphar.2023.1155271 Received 31 January 2023 Accepted 19 April 2023 Published 05 May 2023 Volume 14 - 2023 Edited by Andresa Heemann Betti, Feevale University, Brazil Reviewed by Lekha Sleno, Universit du Qubec Montral, Canada Toby James Athersuch, Imperial College London, United Kingdom Updates Copyright 2023 Quints, Castell and Moreno-Torres
For instance, one study notes that people with excess weight or obesity appear to have lower vitamin B12 levels than people who have a body mass index (BMI) in the normal range ( Additional research has observed that people who voluntarily took vitamin B12 supplements gained between 2.517 fewer pounds (1.27.7 kg) over 10 years than those who did not supplement with this vitamin ( Still, such observational studies cannot confirm whether low vitamin B12 levels are what caused the weight gain, nor whether theyre what protected against low levels
Deplin is also used to treat anxiety and depression
Ezugha H, Goldenthal M, Valencia I, Anderson CE, Legido A, Marks H
The Gray Market and Research Chemical Status In the legal landscape of many countries, BPC-157 exists in a gray area commonly referred to as a "research chemical." In this category, the compound can be manufactured, imported, and sold in certain jurisdictions with labeling disclaimers such as "for research purposes only" or "not for human consumption." This labeling is technically a legal requirement in some regions, but it doesn't prevent individuals from purchasing and using BPC-157 outside official medical channels
However, there are other forms of BPC-157 available - in particular, sublingual capsule tablets which are dissolved under the tongue as well as nasal sprays
